ERBB2 and breast cancer: The principal metabolic changes in HER2-positive BC compared with HER2-negative BC included elevated aerobic glycolysis, enhanced gluconeogenesis, and increased fatty acid biosynthesis with reduced Krebs cycle and Δ9 desaturase.